December 2025 CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system Regulatory clearance of CMR’s ...

CMR Surgical announced today that its second-generation surgical robot, Versius Plus, received FDA 510(k) clearance.

The FDA previously granted marketing authorization for CMR’s first-generation Versius Surgical System in October 2024.

“Built on years of global clinical use data, Versius Plus delivers the flexibility and intelligence today’s healthcare ...

As competition intensifies among surgical robot makers, CMR said its soft tissue platforms are the second most used systems ...

CMR Surgical’s Versius Plus robot’s clearance follows the FDA’s de novo classification of the company’s first-generation ...

Here are the largest medtech funding rounds — all of which equaled or exceeded $150 million — of 2025: Waltham, Massachusetts ...

CMR Surgical said it is on track to begin commercialization of its Versius Plus surgical robotic platform in 2026 in the United States.

CMR Surgical has received FDA clearance for its Versius Plus surgical robotic platform. The clearance covers cholecystectomy ...

Medtronic and CMR Surgical got the FDA’s green light this month, while SS Innovations applied for clearance. Catch up on the ...

Detailed price information for C O N M E D Corp (CNMD-N) from The Globe and Mail including charting and trades.

Big personalities”, “ego problems” and a “toxic culture”- all issues which have led to a shocking review of the surgery team at Lynn’s hospital.